Company Overview
Organon Pharma (Uk) Limited is listed at the official companies registry as Active Private Limited Company. The company was incorporated on Friday 25 September 1964, so this is a well established company. Organon Pharma (Uk) Limited has been in business for 61 years and 6 months. The accounts status is full and the accounts are next due on Wednesday 30 September 2026.
Registered Address

Organon Pharma (Uk) Limited, Shotton Lane, Cramlington, NE23 3JU
Credit Reports Available

These credit rating reports are available now:


Credit Analysts Report
Get Report >>

Standard Credit Report
Get Report >>

Basic Credit Report
Get Report >>

24/7 credit rating data feed - no UK company credit reports are updated faster

Companies House Data
Company NameORGANON PHARMA (UK) LIMITED
Company Number00820771
Registered Office AddressOrganon Pharma (Uk) Limited
 Shotton Lane
 NE23 3JU
Company CategoryPrivate Limited Company
Company StatusActive
Country of OriginUnited Kingdom
Incorporation Date25/09/1964
Accounting Reference Date Day31
Accounting Reference Date Month12
Accounts Next Due Date30/09/2026
Accounts Last Made Up Date31/12/2024
Accounts Account CategoryFULL
Returns Next Due Date07/08/2016
Returns Last Made Up Date10/07/2015
Previous Company NameChanged Date
MERCK SHARP & DOHME LIMITED17 Nov 2020
Directors & Members
Show Resigned
Nicola Barr - Director
(British, 50 years old, born August 1976)
Appointed 01 September 2025
 Active
Anne Bitzer - Director
(French, 45 years old, born January 1981)
Appointed 01 September 2025
 Active
Josef Laskowski - Director
(British, 46 years old, born October 1980)
Appointed 01 March 2024
 Active
Sofia Paulos Ferreira Alves Da Silva - Director
(Portuguese, 49 years old, born September 1977)
Appointed 01 September 2025
 Active
Secretaries
Show Resigned
John Parsons - Secretary
Appointed 28 May 2021
 Active
Other Company Directorships
Nicola Barr
DASHTAG
DERMAVANT HOLDINGS LIMITED
Anne Bitzer
DASHTAG
DERMAVANT HOLDINGS LIMITED
Josef Laskowski
DASHTAG
Sofia Paulos Ferreira Alves Da Silva
No companies found
Balance Sheet Unlock full report
Accounts Date 31-Dec-2024 31-Dec-2014 31-Dec-2013
Balance Sheet
Fixed Assets 264,864,000 264,864,000 263,105,000
Current Assets 303,943,000 303,943,000 333,325,000
Creditors Due Within One Year 120,152,000 120,152,000 113,004,000
Working Cap 183,791,000 183,791,000 220,321,000
Total Assets Less Current Liabilities 448,655,000 448,655,000 483,426,000
Long-term Liabilities 27,928,000 27,928,000 28,298,000
Net Assets 420,727,000 420,727,000 455,128,000
Share Capital & Reserves
Share Cap 201,794,000 201,794,000 201,794,000
Profit & Loss Reserves 125,660,000 125,660,000 160,061,000
Other Reserves 93,273,000 93,273,000 93,273,000
Shareholders Funds 420,727,000 420,727,000 455,128,000
Common Size Financial Analysis Unlock full report
Accounts Date 31-Dec-2024 31-Dec-2014 31-Dec-2013
Tangible Fixed Assets - - -
Fixed Assets 46.6% 46.6% 44.1%
Stocks Inventory 0.5% 0.5% 0.4%
Debtors 29.6% 29.6% 22.0%
Cash Bank In Hand 17.5% 17.5% 31.6%
Current Assets 53.4% 53.4% 55.9%
Creditors Due Within One Year 21.1% 21.1% 18.9%
Net Current Assets Liabilities 32.3% 32.3% 36.9%
Creditors Due After One Year 4.9% 4.9% 4.7%
Accruals Deferred Income - - -
Provisions For Liabilities Charges - - -
Net Assets Liabilities Including Pension Asset Liability 74.0% 74.0% 76.3%
Called Up Share Capital 35.5% 35.5% 33.8%
Share Capital Allotted Called Up Paid 35.5% 35.5% 33.8%
Profit Loss Account Reserve 22.1% 22.1% 26.8%
Shareholder Funds 74.0% 74.0% 76.3%
Capital Employed - - -
Total Assets Less Current Liabilities 78.9% 78.9% 81.1%
Financial Ratio Analysis Unlock full report
Accounts Date 31-Dec-2024 31-Dec-2014 31-Dec-2013
Liquidity Ratio 2.5 2.5 2.9
Solvency Ratio 3.8 3.8 4.2
Reserves to Assets 0.2 0.2 0.3
Secured Creditors Unlock full report
Mortgages Charges 0
Mortgages Outstanding 0
Mortgages Part Satisfied 0
Mortgages Satisfied 0
Assets and Debt Analysis Unlock full report
Accounts Date 31-Dec-2024 31-Dec-2014 31-Dec-2013
Assets 568,807,000 568,807,000 596,430,000
Debt 148,080,000 148,080,000 141,302,000
Net Assets/Debt 420,727,000 420,727,000 455,128,000

The following is based on the accounts data presented in this report sourced from Companies House, however the company has filed later accounts. Our analysis of the latest account can be viewed by unlocking our full report.

The company balance sheet displays a comfortable surplus of working capital. We would normally view this positively. Total reserves including retained profitability and movement in reserves has some deficiency. The balance sheet indicates the substantial net assets of a large company. For the size of the company inferred by the balance sheet the level of net assets suggests a comfortable level of cover for total debts and obligations.

Unlock full report  The following is based on the accounts data presented in this report sourced from Companies House, however the company has filed later accounts. Our analysis of the latest account can be viewed by unlocking our full report.The company balance sheet displays a comfortable surplus of working capital. We would normally view this positively. Total reserves including retained profitability and movement in reserves has some deficiency. The balance sheet indicates the substantial net assets of a large company. For the size of the company inferred by the balance sheet the level of net assets suggests a comfortable level of cover for total debts and obligations.   The following is based on the accounts data presented in this report sourced from Companies House, however the company has filed later accounts. Our analysis of the latest account can be viewed by unlocking our full report.The company balance sheet displays a comfortable surplus of working capital. We would normally view this positively. Total reserves including retained profitability and movement in reserves has some deficiency. The balance sheet indicates the substantial net assets of a large company. For the size of the company inferred by the balance sheet the level of net assets suggests a comfortable level of cover for total debts and obligations.

This review of public record balance sheet and company status information is presented under the terms of Open Government Licence and is for informational purposes only, is general in nature, and is not intended as an opinion or advice for any specific circumstances. The commentary and the colour band score is not a credit rating or credit risk assessment.

This review does not constitute a full credit rating or credit risk assessment based on the full analysis and credit score algorithms used in our credit reports. A full credit report may also provide information relating to trade payment history and county court or court judgments if any.

Public Record Information Unlock full report
Exact Court Judgements
Period of Months Last 12m 13-24m 25-36m 37-48m 49-60m 61-72m
Number of Exact CCJS X Y Y X X Y
Value of Exact CCJS YXY YK S S X KX
Supplier Credit Limits Unlock full report
Date Sector Notified Amount Terms
XK-SXY XKXYXK SXSKXYXK £X,000 XS XYSKS
SK-SYY SKXYXKYKKY KSXX KKXXYXS £YY,000 YS XYSKS SK YXXSXS
YK-SXY XKXYXYYK SXSXYXK £SX,000 XS XYSKS
Payment Records Unlock full report
Payment Records from it's suppliers' company ledger show how a company is paying its suppliers

Payment Analysis

Total Invoices Paid Before
30 days due		 Paid After
30 days due		 Owing Before
30 days due		 Owing after
30 days due
XYX SX K YX X
Company Valuation Analysis Unlock full report

Going Concern Valuation

The going concern valuations value the company on the basis that it continues to trade without the threat of liquidation for the foreseeable future. These valuations are primarily profit and cashflow based.

Valuations Valuation Measures
Estimated High Value £XSI,000 Retained Profit £YX,000
Estimated Mid Value £YY,000 EBIT £SY,000
Estimated Low Value £X,000 EBITDA £SSX,000

Liquidation Valuation

The liquidaton valuation values the company as if it were to cease trading and assets were subject to rapid disposal to cover liabilities. This valuation is primarily asset based.

Valuations Valuation Measures
Estimated High Value £XY,000 Total Assets £XIX,000
Estimated Mid Value £Y,000 Net Assets £YX,000
Estimated Low Value £S,000 Tangible Equity £SX,000

The above valuations are based on our own algorithms and take no account of many factors that can influence actual valuations realized and should not therefore be assumed to be accurate.
Credit Status Checklist Unlock full report
Business Growth Please purchase a report to see true comments
EBITDA Purchase a report to see true comments
Dividends Please purchase a report to see true comments about this company
Retained Profits Retained Profits for this company
Debt Interest Debt Interest for this company
Cash Flow Cash Flow for this company
CCJs CCJs for this company
Age of Company Age of Company for this company
Solvency Solvency for this company
Secured Creditors Secured Creditors for this company
Ownership Ownership for this company


First Report Score: (0-10) X
Financial Status Guide:
10 Very Strong
9 Strong
8 Very Good
7 Good
6 Above Average
5 Average
4 Below Average
3 Poor
2 Weak
1 Very Weak
0 Critical

Risk Score Trend

Risk Rating Unlock full report

This is the credit risk assessment used by one of the top UK credit reference agencies.

Risk Score (1-100) X
Risk Band Description XXMXMXMX SISX
Risk Assessment Meeting of Creditors
Credit Rating XSKX
Altman Z Score Credit Risk Rating Unlock full report

There have been many bankruptcy predictors developed, however none has been so thoroughly tested and broadly accepted as the Altman Z-Score.

Z Score X
Risk Band XY
Risk Band Description The Z Score is not used for small companies where full accounts are not filed because profit and loss account items are required to calculate the score.

Z Score Bands

1 Low Risk 3.00 and above
2 Caution 2.63 - 2.99
3 Risk of Failure within 2 years 1.24 - 2.62
4 High Probability Failure Below 1.24
Other Business around NE23 3JU
No other companies found in the same location
Document Filings
Appointment of Nicola Barr as a director on 1 September 2025
Appointment of Sofia Raquel Paulos Ferreira Alves Da Silva as a director on 1 September 2025
Appointment of Anne Bitzer as a director on 1 September 2025
Termination of appointment of Isabel Vandenberk as a director on 31 July 2025
Confirmation statement made on 10 July 2025 with no updates
Termination of appointment of Sandy Lindsey as a director on 30 May 2025
Change of details for Organon & Co., Inc. as a person with significant control on 3 June 2021
Confirmation statement made on 10 July 2024 with updates
Registered office address changed from Organon Pharma (Uk) Limited Shotton Lane Cramlington England and Wales NE23 3JU United Kingdom to Organon Pharma (Uk) Limited Shotton Lane Cramlington NE23 3JU on 21 June 2024
Registered office address changed from The Hewett Building 14 Hewett Street London EC2A 3NP United Kingdom to Organon Pharma (Uk) Limited Shotton Lane Cramlington England and Wales NE23 3JU on 6 June 2024
Termination of appointment of Simon Khalid Hussain as a director on 29 February 2024
Appointment of Isabel Vandenberk as a director on 1 March 2024
Termination of appointment of Torben Dahl as a director on 29 February 2024
Termination of appointment of Simon Nicholson as a director on 15 February 2024
Appointment of Ms Sandy Lindsey as a director on 1 March 2024
Appointment of Mr Michael Whale as a director on 1 March 2024
Appointment of Mr Josef Ralph Laskowski as a director on 1 March 2024
Confirmation statement made on 10 July 2023 with no updates
Confirmation statement made on 10 July 2022 with no updates
Second filing for the appointment of Torben Dahl as a director
Appointment of Dahl Torben as a director on 28 May 2021
Terms and Conditions Cancellations Contact Us

In using this service you agree to the Terms and Conditions

© 2026 Check Free